Thursday, May 26, 2011

Zoloft Could Pose Risk to Newborns

Zoloft, an antidepressant marketed by Pfizer for the treatment of depression, obsessive-compulsive disorder and anxiety, is being investigated as a potential cause birth defects or malformations.  Studies have shown Zoloft side effects may increase the risk of birth defects when used as early as the first trimester of pregnancy, a time when many women do not even know they are pregnant.

Over the last few years, research has suggested that use of Zoloft during pregnancy may increase the risk of serious and potentially life-threatening health problems for babies, including persistent pulmonary hypertension in newborns (PPHN), heart defects, lung defects, abdominal defects, cranial defects and other malformations.

In 2007, Zoloft was the most prescribed antidepressant in the United States with nearly 30 million prescriptions.  Zoloft is among other drugs that have been linked to birth defects and malformations when used during pregnancy, including the antidepressants Paxil, Lexapro and Prozac, as well as the anti-seizure medication Topamax, which has been linked to a risk of cleft palate and cleft lip.

The attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries.  Our extremely skilled team of attorneys and medical experts are dedicated to ensuring your family receives proper compensation to care for the child in the future.  If you believe your child may have suffered birth defects as a result of the drug Zoloft, please contact us at 1-877-MessaLaw.

No comments:

Post a Comment